The Stroke Association, United Kingdom   Report issue

Foundation Phase 2 Phase 3
Founded: London United Kingdom (1992)

Organization Overview

First Clinical Trial
2004
NCT00124826
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now